Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1994-06-14
1996-10-15
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
53038815, 5303883, 435 7021, 4241491, C12N 520, C07K 1608
Patent
active
055653545
ABSTRACT:
Monoclonal antibodies effective for the diagnosis and treatment of diseases caused by infection with hepatitis B have been prepared from a cell line obtained by fusing a xenogeneic hybridoma designated SPAZ 4 with blood cells of a patient immunized with hepatitis B vaccine. The invention also provides cocktails of the above monoclonal antibodies specific for different epitopes of hepatitis B surface antigen.
REFERENCES:
patent: 4346073 (1982-08-01), Aronson et al.
patent: 4491632 (1985-01-01), Wands et al.
patent: 4608337 (1986-08-01), Croce et al.
patent: 4634666 (1987-01-01), Engleman et al.
patent: 4883752 (1989-11-01), Eda et al.
Ogata et al (1993) Proc. Nat'l. Acad. Sci. 90: 3014-3018.
Matsui et al. (1982) Nichi Dai Ishi (J. Nihon Univ. Med. Assoc.) 41(12): 1163-1171 (English translation, pp. 1-23).
Matsui et al (1982) Biol. Abstr. 77(6): 4766, Abstract# 43590.
Goldstein et al. (1986) Transplantation 42: 507-511.
Ehrlich et al. (1992) Hum. Antibod. Hybridomas 3: 2-7.
Perillo et al (1990) N. Engl. J. Med. 323: 295-301.
Janssen et al (1994) Antiviral Res. 23: 251-257.
Hoofnagle et al "Serologic Responses in HB; In Viral Hepatitis" (Vyas et al. eds.) Franklin Press., 1978, pp. 219-242.
Roitt (1991) "Essential Immunology", Blackwell Scientific Publications, Oxford, pp. 65-68 & 74.
Burragi et al (1985) Cancer Res. 45: 3378-3387.
Goding J. W. (1983) "Monoclonal Antibodies", Academic Press, Inc., Orlando, pp. 118-125.
Davidsohn et al (1974) "Clinical Diagnosis By Laboratory Methods", W. B. Saunders Co., Philadelphia, pp. 848-851 & 861-865.
Roitt (1991) "Essential Immunology", Blackwell Scientific Publications, Oxford, pp. 68-75.
Cotran et al (1989) "Robbins Pathologic Basis of Disease", W. B. Saunders Company, Philadelphia, pp. 927-928.
Todo et al (1991) Hepatology 13: 619-626.
Demetris et al (1986) Am. J. Pathol. 125: 161-172.
Starzi et al (1989) Transplantation Proceedings 21: 2197-2200.
Andris et al (1992) J. Immunology 149: 4053-4059.
Kozbor et al (1984) J. Immunol. 133: 3001-3005.
Teng et al (1983) Proc Nat'l Acad Sci.80: 7308-7312.
Steinitz et al (1979) J. Clin. Lab. Immunol. 2: 1-7.
Matsui et al (1982) Nichidai Igaku Zasshi 41(12); 1163-1172 [& Biol. Abstr. 77(6); 4766, #43590].
Wands et al (1981) Gastroenterology 80: 225-232.
Imai et al (1982) J. Immunol. 128: 69-72.
Ichimori, et al., Biochem. & Biophysical Res. Comm., vol. 129, pp. 26-33 1985.
Stricker, E. A. M. et al. 1985. "A Human Monoclonal IgG1.lambda. Anti-Hepatitis B Surface Antibody " Scan. J. Immunol. 22:337-343.
Harada, K. et al. 1989 "Human-Human Hybridomas Secreting Hepatitis B Virus Neutralizing Antibodies" Bio/Technology 7:374-377.
Ichimori, Y. et al. 1987. "Establishment of Hybridoma Secreting Human Monoclonal Antibody Against Hepatitis B Virus Surface Antigen" Bioch. bioph. Res. Comm. 142(3):805-812.
Ebert Ray F.
Hutzell Paula K.
Sandoz Ltd.
LandOfFree
Production of human monoclonal antibodies specific for hepatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of human monoclonal antibodies specific for hepatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of human monoclonal antibodies specific for hepatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1245306